Pharmafile Logo
Pharmafocus logo
Advanced Search

Quality fears prompt cancer drug recalls

November 25, 2011
Manufacturing and Production Ben Venue, EU, Hong Kong, manufacturing

Regulatory authorities around the world are recalling cancer drugs manufactured by Boehringer Ingelheim’s Ben Venue Laboratories subsidiary after an inspection …

News

Mixed results for UK in international health survey

November 25, 2011
Sales and Marketing NHS, OECD, healthcare

The NHS in England does not perform well on some patient outcomes for cancer, stroke and respiratory diseases given the …

News
NICE hq pic

NICE okays Eliquis for blood clots after surgery

November 25, 2011
Research and Development, Sales and Marketing BMS, Eliquis, NICE, Pfizer

NICE is recommending Pfizer and Bristol-Myers Squibb’s Eliquis for blood clots after surgery. Specifically, NICE has said that Eliquis (apixaban) …

News
screen_shot_2011-11-24_at_13

RSA announces raft of new appointments

November 24, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

RSA, the global life sciences executive search and interim management firm, has announced a series of new appointments. RSA Switzerland …

Appointment

Adaptive Trial Design

November 24, 2011
Research and Development

Despite the burgeoning interest in Adaptive Trial Design (ATD), an extremely powerful tool when used effectively in the appropriate circumstances, …

Feature
White paper

NICE confirms ‘no’ for colorectal cancer drugs

November 24, 2011
Sales and Marketing Erbitux, NICE, Vectibix, avastin, colorectal cancer

 

News
glyn_edwards

Glyn Edwards appointed interim chief executive of the BioIndustry Association

November 24, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, Glyn Edwards

The BioIndustry Association (BIA) has appointed Glyn Edwards as its interim chief executive effective immediately. Edwards was previously chief executive …

Appointment
Lucentis image

Lucentis not backed by NICE for new licence

November 24, 2011
Sales and Marketing Lucentis, NICE, Novartis, Ozurdex

NICE has not recommended Novartis’ eye disease drug Lucentis due to ‘gaps and uncertainties’ in the manufacturer’s submission. In draft …

News
screen_shot_2011-11-24_at_09

Professor Sir Michael Rawlins reappointed as NICE chairman

November 24, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, Rawlins

The National Institute for Health and Clinical Excellence (NICE) has reappointed Professor Sir Michael Rawlins as NICE chairman for a …

Appointment

Private sector role in NHS commissioning opposed

November 23, 2011
Medical Communications, Sales and Marketing BMA, CCGs, NHS, PCT clusters

Private firms could be allowed to support clinical commissioning groups, the new NHS budget holders in England.New draft guidance from the Department …

News

Future of public health uncertain, says Forum

November 23, 2011
Sales and Marketing Future Forum, NHS, NHS reforms

The Department of Health has been urged to clarify the NHS’s responsibilities in relation to public health.The independent NHS Future …

News
Alasdair Williams

Red Door launches Grapevine ‘localisation’ service

November 23, 2011
Medical Communications Grapevine, Red Door

 Red Door Communications has launched Grapevine – a new healthcare ‘localisation’ initiative and appointed Alasdair Williams as its head. Grapevine …

News

Pfizer hatches mail order plan for Lipitor

November 23, 2011
Sales and Marketing Lipitor, Pfizer, US, generics

Pfizer is preparing to launch a new mail order service offering cut-price Lipitor direct to patients in the US.The firm …

News

Big pharma counts cost of R&D decline

November 23, 2011
Research and Development Deloitte, GSK, IIR, R&D productivity

Leading pharma firms are getting around 30% less on their investments in research and development compared to last year, according …

News
Vioxx

Merck pays $950 million to settle Vioxx charges

November 23, 2011
Sales and Marketing Department of Justice, Merck, Vioxx, marketing violations, off label marketing

Merck will pay out $950 million and admit that it illegally marketed its painkiller Vioxx in the US. It will …

News

Pharmalink elects Anders Wiklund as its new board chairman

November 23, 2011
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Pharmalink

Swedish speciality firm Pharmalink AB has elected Anders Wiklund to serve as its new chairman of the board. In addition …

Appointment

Pancreatic cancer sees lowest improvement in cancer survival

November 23, 2011
Medical Communications, Research and Development Cancer, Macmillan, pancreatic

A new cancer survival study shows that pancreatic cancer continues to have one of the worst mortality rates.  The study …

News

Changes to the EMA’s registration process for SMEs

November 22, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates

The European Medicines Agency (EMA) has recently made changes to its process for the registration of micro, small or medium-sized …

News
Press release

Doxil shortages exacerbated as Ben Venue shutters plant

November 22, 2011
Manufacturing and Production Doxil, J&J, JJ, manufacturing and production

An acute shortage of Johnson & Johnson’s cancer drug Doxil (doxorubicin) in the US could get worse following a decision …

News

Pharma manufacturing news in brief

November 22, 2011
Manufacturing and Production manufacturing and production

Pfizer and Julphar plan facilities in Saudi Arabia, plus updates from Custom Processing Services, Metrics and China’s Tianyin Pharma. Gulf …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026